Background and Purpose—The purpose of these guidelines is to provide an up-to-date
comprehensive set of recommendations in a single document for clinicians caring for adult …

Efficacy of patent foramen ovale (PFO) closure in patients with cryptogenic stroke remains a
matter of debate. We performed a comprehensive meta-analysis of available randomized …

Introduction Patent foramen ovale closure reduces recurrence of cryptogenic ischaemic
stroke compared to anti-platelet therapy. Our goal was to determine procedure volumes and …

Background: The risk of paradoxical embolism (RoPE) score calculates the probability that
patent foramen ovale (PFO) is causally related to stroke (PFO attributable fraction, PFOAF) …

Objective: The aim of this study was to assess the association between the presence of a
right-to-left shunt (RLS) and neurological decompression sickness (NDCS) and …

BACKGROUND Most of the randomized clinical trials that led to the wide use of non-vitamin
K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation (AF) …

Background The Cocoon patent foramen ovale (PFO) Occluder is a new generation nitinol
alloy double-disk device coated with nanoplatinum, likely useful in patients with nickel …

Decompression sickness (DCS) is the symptomatic involvement of one or more organ
systems by bubbles released into tissues and blood vessels from a previously dissolved …

Patent foramen ovale (PFO) is a standard variant that is present in 25% of the whole adult
population. In a certain population, PFO can lead to cerebrovascular accidents. Mechanism …

Stroke is the second leading cause of death worldwide and fifth leading cause of death in
the United States (1). The term cryptogenic strokes is used to define strokes for which a …